, using the EuResist database, examined trends of TDR and acquired drug resistance (ADR) in Europe in 1981–2019, comparing late presenters (LP) and non-late presenters (NLP), finding a decreasing trend in both TDR and ADR, and similar TDR frequencies and mutation profiles in LP and NLP.
1
—
—